Morningstar brands and products Company Portfolio ...

Ninety-nine percent of trial participants elected to participate in the ADHERE+ open-label extension. The safety results were generally consistent with the known safety profile of VYVDURA in ...

WASHINGTON, Jan. 29, 2025 /PRNewswire/ -- Adhere+, a telehealth company focused on improving patient outcomes through a SaaS-based telehealth care plan adherence and medication compliance ...